Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

Q06455 (MTG8_HUMAN) Homo sapiens (Human)

Protein CBFA2T1 UniProtKBInterProSTRINGInteractive Modelling

604 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6); 8 identical sequences: Pongo abelii: A0A2J8UG40; Pan troglodytes: A0A2I3SCI0, A0A6D2W665; Pan paniscus: A0A2R9AHS9; Gorilla gorilla gorilla: A0A2I2ZQG2; Callithrix jacchus: F7GN17; Nomascus leucogenys: A0A2I3GHW6; Cebus imitator: A0A2K5QH32

Available Structures

9 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
The Solution structure of the eTAFH domain of AML1-ETO complexed with HEB peptide Heteromer
Q99081;
119-216
Assess
Complex structure of AML1-ETO NHR2 domain with HEB fragment Heteromer
Q99081;
341-400
Assess
Solution structure of the MYND domain from AML1-ETO complexed with SMRT, a corepressor Heteromer
Q9Y618;
510-559
ZN;
Assess
Structure of the AML1-ETO Nervy Domain - PKA(RIIa) complex and its contribution to AML1-ETO activity Heteromer
P13861;
437-467
Assess
The tetramer structure of the nervy homolgy two (NHR2) domain of AML1-ETO is critical for AML1-ETO'…homo-4-mer342-400
Assess
Solution Structure of ETO-TAFH refined in explicit solventmonomer119-225
Assess
Solution structure of the eTAFH domain from the human leukemia-associated fusion protein AML1-ETOmonomer120-222
Assess
Solution structure of the MYND domain from human AML1-ETOmonomer510-559
ZN;
Assess
Solution Structure of zf-MYND Domain of Protein CBFA2TI (Protein MTG8)monomer505-551
ZN;
Assess

5 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1wq6.1.Bmonomer0.67342-400
100.00
Assess
2pp4.1.Amonomer0.66119-224
99.06
Assess
2odd.1.Bmonomer0.65510-559
ZN;100.00
Assess
2h7b.1.Amonomer0.62120-222
99.03
Assess
6vmb.1.Hmonomer0.61444-497
12.96
Assess

21 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 21wq6.1.Bmonomer0.67315-373
100.00
Assess
Isoform 22pp4.1.Amonomer0.6792-197
99.06
Assess
Isoform 22odd.1.Bmonomer0.64483-532
ZN;100.00
Assess
Isoform 22h7b.1.Amonomer0.6293-195
99.03
Assess
Isoform 26vmb.1.Hmonomer0.61417-470
12.96
Assess
Isoform 32pp4.1.Amonomer0.66130-235
99.06
Assess
Isoform 31wq6.1.Bmonomer0.66353-411
100.00
Assess
Isoform 32odd.1.Bmonomer0.65521-570
ZN;100.00
Assess
Isoform 32h7b.1.Amonomer0.62131-233
99.03
Assess
Isoform 36vmb.1.Hmonomer0.61455-508
12.96
Assess
Isoform 41wq6.1.Bmonomer0.68305-363
100.00
Assess
Isoform 42pp4.1.Amonomer0.6782-187
99.06
Assess
Isoform 42odd.1.Bmonomer0.67473-519
ZN;100.00
Assess
Isoform 42h7b.1.Amonomer0.6283-185
99.03
Assess
Isoform 46vmb.1.Hmonomer0.61407-460
12.96
Assess
Isoform 52pp4.1.Amonomer0.66119-224
99.07
Assess
Isoform 52h7b.1.Amonomer0.61120-222
99.03
Assess
Isoform 51wq6.1.Bmonomer0.54342-400
100.00
Assess
Isoform 62pp4.1.Amonomer0.6792-197
99.06
Assess
Isoform 62h7b.1.Amonomer0.6193-195
99.03
Assess
Isoform 61wq6.1.Bmonomer0.57315-373
100.00
Assess